Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan + minocycline vs vonoprazan + amoxicillin dual regimens for H. pylori eradication
ChiCTR2400086342Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vonoprazan, minocycline and amoxicillin in Helicobacter pylori infection (4 arms), sponsored by Peking University First Hospital. Primary endpoint: H. pylori eradication rate. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
vonoprazanminocyclineamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2400086342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086342.